interferoninduc
transmembran
protein
potent
antivir
protein
enhanc
cellular
resist
varieti
pathogen
includ
influenza
viru
classic
defin
interferonstimul
gene
express
cell
rapidli
upregul
respons
type
ii
interferon
found
rapidli
upregul
cell
follow
activ
occur
independ
type
ii
interferon
interferon
regulatori
factor
upregul
effector
cell
protect
cell
viru
infect
impart
surviv
advantag
site
viru
infect
result
show
express
effector
cell
crucial
cell
mediat
effector
function
highlight
interferon
independ
pathway
induct
target
could
effect
approach
har
activ
infect
prevent
cell
equip
varieti
mechan
protect
viru
infect
earli
detect
viral
infect
innat
receptor
trigger
product
type
interferon
ifn
turn
signal
express
interferonstimul
gene
isg
within
host
cell
protein
encod
gene
interfer
viral
replic
enhanc
abil
uninfect
cell
resist
infect
interferoninduc
transmembran
potent
antivir
protein
exhibit
protect
broad
rang
virus
includ
orthomyxovirus
flavivirus
filovirus
coronavirus
particularli
effect
protect
influenza
viru
infect
absenc
singl
antivir
protein
associ
exacerb
influenza
infect
mice
human
knockout
mice
succumb
subleth
dose
influenza
viru
human
express
function
defect
allel
variant
prone
sever
influenza
viru
infect
inhibit
viral
entri
earliest
step
viru
life
cycl
prevent
virus
travers
lipid
bilay
cell
access
cytoplasm
posit
lipid
membran
endosom
lysosom
trap
endocytos
viru
particl
within
vesicl
interf
format
viru
fusion
pore
result
virus
requir
phdepend
trigger
viral
fusion
machineri
escap
endosom
cytosol
highli
suscept
antivir
activ
cell
type
includ
respiratori
epitheli
cell
tissu
resid
memori
cell
constitut
express
mani
other
express
antivir
protein
steadyst
condit
upregul
express
exposur
type
type
ii
interferon
express
level
tightli
regul
ubiquitin
ligas
reduc
baselin
level
ubiquitin
antivir
protein
therebi
promot
turnov
whether
express
regul
differ
distinct
cell
type
remain
unclear
immun
cell
often
carri
effector
function
site
infect
therefor
directli
expos
virusinfect
cell
cell
like
benefit
greatli
regul
express
antivir
protein
previous
report
dendrit
cell
station
within
lung
upregul
follow
influenza
viru
infect
process
driven
exposur
type
interferon
crucial
cell
success
traffic
influenza
viral
antigen
lung
drain
lymph
node
ln
without
becom
infect
perish
en
rout
tissu
resid
memori
cell
airway
lung
skin
brain
constitut
express
associ
enhanc
resist
viral
infect
therefor
longterm
surviv
within
peripher
tissu
extend
research
investig
express
pattern
driver
express
cell
activ
infiltr
influenza
virusinfect
lung
tissu
find
rapidli
upregul
cell
follow
activ
drain
ln
express
maintain
cell
infiltr
site
viru
infect
upregul
effector
cell
protect
cell
viru
infect
impart
surviv
advantag
site
viru
infect
interestingli
express
activ
cell
driven
type
ii
interferon
reli
interferon
regulatori
factor
result
show
express
effector
cell
crucial
cell
mediat
effector
function
highlight
interferon
independ
pathway
induct
target
could
approach
har
activ
infect
prevent
ko
rfp
zhang
jackson
laboratori
ko
x
gbtigfp
ifnar
ko
ifnar
x
ko
ko
ko
provid
taniguchi
x
ko
mice
bred
inhous
hous
specif
pathogenfre
condit
anim
facil
peter
doherti
institut
infect
immun
univers
melbourn
experi
approv
perform
accord
institut
anim
care
use
committe
guidelin
univers
melbourn
mice
infect
intranas
encod
ova
epitop
within
neuraminidas
stalk
gener
provid
prof
turner
monash
univers
melbourn
australia
total
respiratori
tract
trt
infect
mice
anesthet
inhal
anaesthet
infect
pfu
volum
total
cell
lysat
run
sdspage
gel
invitrogen
transfer
onto
nitrocellulos
membran
membran
stain
antibodi
mous
abcam
actin
sigma
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antibodi
sigma
use
protein
detect
cell
purifi
ln
spleen
mice
cell
purifi
deplet
step
use
antibodi
mhc
class
ii
gk
yt
follow
incub
antirat
iggcoupl
magnet
bead
dynal
biotech
follow
manufactur
protocol
cell
prepar
pure
determin
flow
cytometri
purifi
cell
plate
cell
per
well
flatbottom
tissu
cultur
plate
falcon
coat
altern
oti
cell
plate
cell
per
well
flatbottom
tissu
cultur
plate
falcon
siinfekl
peptid
influenza
viru
highyield
reassort
aaichi
respect
express
surfac
glycoprotein
addit
use
season
influenza
viru
strain
anew
new
well
strain
aport
port
virus
grown
embryon
chicken
egg
standard
procedur
titr
infecti
viru
determin
plaqu
assay
madindarbi
canin
kidney
mdck
cell
cell
magnet
enrich
describ
sort
purifi
ln
spleen
mice
experi
label
cell
trace
violet
cultur
cellswel
serum
free
media
influenza
viru
moi
hour
cell
wash
remov
free
viru
cultur
rpmi
fc
hour
suscept
infect
measur
intracellular
stain
nucleoprotein
np
influenza
virus
use
antiinfluenza
npfitc
abcam
total
transgen
splenocyt
oti
mice
cultur
day
splenocyt
puls
ova
peptid
ml
rpmi
supplement
fc
mm
glutamin
antibiot
cultur
dilut
day
fresh
medium
contain
uml
day
cell
collect
cell
transfer
recipi
mice
via
intraven
iv
inject
total
volum
pb
perfus
lung
tissu
inflat
oct
immedi
embed
oct
frozen
section
cut
use
cryostat
tissu
section
fix
aceton
block
serumfre
protein
block
stain
dapi
imag
acquir
zeiss
microscop
object
acquir
imag
process
use
imagej
softwar
singl
cell
suspens
prepar
spleen
mechan
disrupt
mice
perfus
prior
harvest
lung
tissu
incub
h
ml
collagenas
type
worthington
mgml
rpmi
supplement
fc
dnase
roch
cell
stain
min
ice
appropri
mixtur
monoclon
antibodi
wash
pb
bsa
conjug
monoclon
antibodi
obtain
bd
pharmingen
biolegend
includ
b
nptetram
made
hous
level
analys
use
bd
cytometr
bead
array
cba
mous
inflamm
kit
legendplex
biolegend
san
diego
ca
usa
accord
manufactur
instruct
data
analys
graphpad
prism
indic
statist
test
p
p
p
classic
defin
interferon
stimul
gene
isg
whose
express
known
upregul
respons
type
ii
interferon
previous
demonstr
cell
express
howev
follow
crosslink
tcr
trigger
activ
tcell
transient
upregul
express
antivir
protein
fig
investig
upregul
activ
cell
respons
interferon
signal
cell
purifi
wild
type
wt
mice
ifnar
ko
mice
lack
receptor
therefor
unabl
respond
type
interferon
ko
mice
unabl
synthes
interferon
gamma
activ
vitro
use
plate
bound
day
later
express
day
activ
cell
measur
fig
cell
lack
receptor
upregul
express
follow
tcr
engag
fig
activ
cell
defect
synthesi
fig
determin
redund
type
ii
interferon
signal
pathway
exclud
involv
either
cytokin
cell
activationinduc
express
use
mice
lack
receptor
cell
isol
anim
fail
express
respons
type
ii
interferon
exposur
confirm
cell
lack
respons
type
ii
interferon
fig
follow
vitro
activ
cell
describ
observ
upregul
express
albeit
less
effect
fig
indic
induct
express
engag
tcr
least
part
independ
type
ii
interferon
signal
interestingli
ifn
signal
requir
tcr
engag
induc
upregul
crucial
evok
express
follow
exposur
viru
show
infect
wt
ifnar
ko
ko
cell
influenza
viru
cultur
cell
vitro
hr
infect
protocol
result
roughli
total
wt
ko
cell
infect
influenza
viru
measur
intracellular
stain
viru
nuclear
protein
np
fig
wt
ko
cell
upregul
express
within
hr
exposur
influenza
viru
fig
tcell
lack
abil
respond
type
interferon
increas
express
respons
viru
fig
collect
data
demonstr
distinct
signal
pathway
drive
express
cell
follow
tcr
engag
exposur
influenza
viru
addit
type
ii
interferon
cytokin
includ
member
famili
cytokin
ie
known
induc
express
could
detect
presenc
type
ii
interferon
well
supernat
cell
cultur
follow
tcr
engag
fig
investig
secret
factor
releas
cell
activ
act
paracrin
manner
induc
express
purifi
ovalbumin
ova
specif
cell
oti
mice
cocultur
cell
polyclon
cell
mice
siinfekl
peptid
ad
cultur
activ
transgen
oti
cell
day
post
cocultur
activ
oti
cell
separ
bystand
cell
express
determin
cell
popul
fig
consist
prior
studi
follow
exposur
cognat
antigen
siinfekl
oti
cell
upregul
express
fig
contrast
bystand
cell
isol
well
therefor
expos
cytokin
milieu
upregul
suggest
secret
factor
drive
activ
induc
upregul
cell
fig
interferoninduc
upregul
previous
shown
driven
transcript
factor
interferon
regulatori
factor
next
determin
transcript
factor
also
regul
express
follow
tcr
engag
first
confirm
cell
isol
mice
defici
either
show
equival
level
activ
expans
respons
tcr
crosslink
cell
purifi
either
wt
ko
ko
x
ko
mice
label
carboxyfluorescein
succinimidyl
ester
cfse
activ
vitro
plate
bound
day
observ
similar
prolifer
profil
fig
could
recov
similar
number
divid
cell
fig
cultur
wt
ko
cell
confirm
defici
transcript
factor
impact
cell
activ
determin
involv
tcr
engagementinduc
express
purifi
cell
wt
ko
mice
activ
cell
describ
day
postactiv
measur
express
cell
defici
upregul
follow
tcr
engag
indic
transcript
factor
requir
activationinduc
express
fig
gain
insight
kinet
tcr
engagementinduc
express
label
cell
violet
trace
membran
dye
activ
cell
vitro
platebound
day
sort
purifi
cell
group
accord
number
divis
cell
undergon
ie
divis
divis
divis
divis
assess
group
cell
express
found
cell
undergon
round
divis
could
upregul
detect
fig
next
assess
express
divid
tcell
increas
resist
influenza
viru
infect
violet
trace
dyelabel
cell
activ
vitro
describ
day
infect
panel
differ
influenza
viru
strain
hr
later
proport
infect
cell
flunp
undergo
divis
determin
fig
differ
influenza
viru
strain
show
strike
differ
abil
infect
cell
infect
rate
rang
gener
observ
less
infect
cell
undergon
round
divis
compar
cell
undergon
round
divis
thu
cell
undergo
divis
express
antivir
protein
increas
resist
influenza
viru
infect
directli
determin
enhanc
resist
activ
cell
influenza
viru
infect
mediat
transgen
wt
oti
cell
ko
oti
cell
activ
vitro
day
infect
differ
influenza
virus
multipl
infect
moi
hr
later
percentag
virusinfect
cell
determin
fig
four
strain
influenza
viru
test
activ
cell
defici
express
infect
significantli
higher
level
indic
express
protect
effector
cell
influenza
viru
infect
fig
next
investig
express
upregul
effector
cell
vivo
influenza
viru
infect
whether
impact
abil
mediat
effector
function
first
track
kinet
express
cell
activ
mice
influenza
viru
infect
mice
seed
congen
mark
oti
cell
control
green
fluoresc
protein
gfp
express
tcr
transgen
cell
specif
glycoprotein
b
herp
simplex
viru
gbti
prior
intranas
infect
recombin
influenza
viru
express
model
antigen
ova
day
post
infect
pi
transgen
cell
popul
sort
purifi
lungdrain
lymph
node
ln
level
express
determin
day
pi
effector
oti
cell
isol
ln
mice
express
gbti
cell
fig
immunofluoresc
analysi
ln
day
pi
reveal
transgen
cell
similar
locat
confirm
mere
inflammatori
environ
suffici
naiv
cell
upregul
express
fig
express
pattern
observ
uniqu
transgen
tcell
endogen
activ
cell
recov
lung
drain
ln
day
pi
display
similar
pattern
express
fig
thu
cell
within
ln
undergon
cognat
antigen
recognit
upregul
vivo
effector
oti
cell
recov
lung
day
pi
also
express
suggest
activ
cell
retain
express
even
exit
ln
infiltr
infect
tissu
fig
confirm
express
vivoactiv
cell
associ
increas
resist
cell
influenza
viru
infect
mice
seed
wt
ko
oti
cell
infect
intranas
within
day
pi
oti
cell
popul
purifi
ln
spleen
infect
vitro
panel
influenza
virus
infect
effici
assess
percentag
influenza
viru
np
cell
measur
hr
later
consist
result
obtain
use
vitroactiv
cell
see
fig
effector
oti
cell
activ
vivo
lack
express
also
suscept
influenza
viru
infect
compar
wt
effector
oti
cell
fig
next
assess
pattern
express
correspond
enhanc
resist
influenza
viru
infect
also
featur
endogen
influenza
specif
cell
infect
wt
ko
mice
influenza
viru
day
pi
influenza
viru
nuclear
protein
np
specif
cell
nptetram
sort
purifi
lung
drain
ln
spleen
fig
confirm
wt
nptetram
cell
express
elev
level
fig
test
express
increas
resist
influenza
specif
cell
viru
infect
infect
vitro
either
wt
ko
nptetram
cell
panel
influenza
virus
measur
proport
infect
cell
hr
later
stain
express
viral
nuclear
protein
consist
result
obtain
use
vitroactiv
cell
see
fig
effector
oti
cell
activ
vivo
see
fig
find
endogen
vivo
activ
influenza
npspecif
cell
lack
express
also
suscept
influenza
viru
infect
compar
npspecif
cell
could
upregul
antivir
protein
fig
final
determin
upregul
effector
cell
provid
surviv
advantag
render
resist
viru
infect
assess
equal
number
vitroactiv
wt
ko
oti
cell
transfer
mice
infect
influenza
viru
day
prior
control
receiv
intranas
treatment
inflammatori
agent
lp
ratio
absolut
number
wt
ko
oti
cell
spleen
lung
measur
hr
later
equival
proport
wt
ko
oti
cell
observ
spleen
lung
follow
transfer
mice
receiv
inflammatori
agent
lp
indic
wt
ko
oti
cell
infiltr
tissu
effect
fig
fig
contrast
observ
equival
ratio
wt
ko
oti
cell
spleen
mice
infect
influenza
viru
observ
wt
oti
cell
lung
suggest
ko
oti
disadvantag
site
viru
infect
fig
fig
overal
experi
show
express
effector
cell
infiltr
site
viru
infect
provid
cell
surviv
advantag
allow
mediat
effector
function
without
becom
target
infect
pharmacolog
induct
could
repres
broadspectrum
therapeut
treatment
rang
pathogen
agent
although
inject
type
ifn
induc
antivir
respons
undesir
target
effect
associ
type
therapi
limit
current
clinic
use
refin
approach
trigger
specif
induct
antivir
protein
independ
ifn
provid
antivir
resist
minim
side
effect
show
upregul
cell
independ
ifn
signal
defin
har
nonifn
pathway
induct
could
target
antivir
therapeut
approach
provid
covet
antivir
action
avoid
undesir
pleiotrop
effect
interferon
treatment
